Nu Skin Enterprises, Inc.
NUS
$7.38
-$0.065-0.87%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 397.78% | -534.90% | 107.02% | -22,087.24% | -107.32% |
Total Depreciation and Amortization | -13.64% | -5.03% | -1.60% | -4.52% | -0.79% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -392.00% | 315.15% | -94.57% | 793.83% | 97.23% |
Change in Net Operating Assets | -282.08% | 490.18% | 33.73% | 87.52% | -264.56% |
Cash from Operations | -98.49% | -17.97% | -38.62% | 1,443.31% | -93.87% |
Capital Expenditure | -7.96% | -46.38% | -5.82% | 33.86% | 39.75% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 235.03% | -150.71% | 602.21% | -113.51% | -39.46% |
Cash from Investing | 1,432.73% | -108.06% | 23.26% | 7.89% | 39.85% |
Total Debt Issued | -- | -100.00% | -- | -- | -- |
Total Debt Repaid | -283.45% | 0.39% | -58.07% | -24.01% | -2,447.18% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -10,364.41% | -11.32% | 11.67% | 96.83% | -950.56% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.64% | 0.00% | -0.03% | -0.10% | 84.54% |
Other Financing Activities | -- | -- | -- | 100.00% | -- |
Cash from Financing | -281.18% | -51.59% | 0.14% | 9.82% | -57.69% |
Foreign Exchange rate Adjustments | 113.28% | -227.20% | 445.35% | 61.94% | -232.72% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 141.32% | -1,267.32% | -70.12% | 126.92% | -291.38% |